192 related articles for article (PubMed ID: 23703058)
1. [Control of epilepsy in adult patients with tuberous sclerosis].
Gallardo-Tur A; García-Martín G; Chamorro-Muñoz MI; Romero-Godoy J; Romero-Acebal M
Rev Neurol; 2013 Jun; 56(11):562-6. PubMed ID: 23703058
[TBL] [Abstract][Full Text] [Related]
2. [Aetiology and treatment of epilepsy in a series of 1,557 patients].
Torres-Ferrús M; Toledo M; González-Cuevas M; Seró-Ballesteros L; Santamarina E; Raspall-Chaure M; Sueiras-Gil M; Cambrodí-Masip R; Sarria S; Álvarez-Sabín J; Salas-Puig J
Rev Neurol; 2013 Oct; 57(7):306-12. PubMed ID: 24052441
[TBL] [Abstract][Full Text] [Related]
3. Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs.
Overwater IE; Bindels-de Heus K; Rietman AB; Ten Hoopen LW; Vergouwe Y; Moll HA; de Wit MC
Epilepsia; 2015 Aug; 56(8):1239-45. PubMed ID: 26046563
[TBL] [Abstract][Full Text] [Related]
4. Epilepsy in TSC: certain etiology does not mean certain prognosis.
Vignoli A; La Briola F; Turner K; Scornavacca G; Chiesa V; Zambrelli E; Piazzini A; Savini MN; Alfano RM; Canevini MP
Epilepsia; 2013 Dec; 54(12):2134-42. PubMed ID: 24304436
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic possibilities in refractory epilepsy in tuberous sclerosis complex].
Puertas-Martin V; Carreras-Saez I; Marana A; Ruiz-Falco Rojas ML; Cantarin-Extremera V; Calleja-Gero ML
Rev Neurol; 2014 Jun; 58(12):529-35. PubMed ID: 24915028
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of rapamycin in treatment of children with epilepsy complicated with tuberous sclerosis].
Zou L; Liu Y; Pang L; Ju J; Shi Z; Zhang J; Chen X; Su X; Hu L; Shi X; Yang X
Zhonghua Er Ke Za Zhi; 2014 Nov; 52(11):812-6. PubMed ID: 25582464
[TBL] [Abstract][Full Text] [Related]
7. Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex.
van der Poest Clement EA; Sahin M; Peters JM
J Child Neurol; 2018 Jul; 33(8):519-524. PubMed ID: 29687739
[TBL] [Abstract][Full Text] [Related]
8. Lacosamide use in the treatment of refractory epilepsy in tuberous sclerosis complex.
Geffrey AL; Belt OD; Paolini JL; Thiele EA
Epilepsy Res; 2015 May; 112():72-5. PubMed ID: 25847341
[TBL] [Abstract][Full Text] [Related]
9. Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial.
Collins JJ; Tudor C; Leonard JM; Chuck G; Franz DN
J Child Neurol; 2006 Jan; 21(1):53-7. PubMed ID: 16551454
[TBL] [Abstract][Full Text] [Related]
10. [Characterisation of the paediatric population of Costa Rica with tuberous sclerosis and a description of the behaviour of the associated epilepsy].
Ulate-Campos A; Benavides-Lara A; Hernández L
Rev Neurol; 2013 Dec; 57(11):489-94. PubMed ID: 24265142
[TBL] [Abstract][Full Text] [Related]
11. The effects of the ketogenic diet in refractory partial seizures with reference to tuberous sclerosis.
Coppola G; Klepper J; Ammendola E; Fiorillo M; della Corte R; Capano G; Pascotto A
Eur J Paediatr Neurol; 2006 May; 10(3):148-51. PubMed ID: 16632392
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.
French JA; Lawson JA; Yapici Z; Ikeda H; Polster T; Nabbout R; Curatolo P; de Vries PJ; Dlugos DJ; Berkowitz N; Voi M; Peyrard S; Pelov D; Franz DN
Lancet; 2016 Oct; 388(10056):2153-2163. PubMed ID: 27613521
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
Kotulska K; Chmielewski D; Borkowska J; Jurkiewicz E; Kuczyński D; Kmieć T; Łojszczyk B; Dunin-Wąsowicz D; Jóźwiak S
Eur J Paediatr Neurol; 2013 Sep; 17(5):479-85. PubMed ID: 23567018
[TBL] [Abstract][Full Text] [Related]
14. Epilepsy in Tuberous Sclerosis: Phenotypes, Mechanisms, and Treatments.
Saxena A; Sampson JR
Semin Neurol; 2015 Jun; 35(3):269-76. PubMed ID: 26060906
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of epilepsy in glioblastomas.
Toledo M; Sarria-Estrada S; Quintana M; Maldonado X; Martinez-Ricarte F; Rodon J; Auger C; Salas-Puig J; Santamarina E; Martinez-Saez E
Clin Neurol Neurosurg; 2015 Dec; 139():166-71. PubMed ID: 26489387
[TBL] [Abstract][Full Text] [Related]
16. Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex.
Jóźwiak S; Kotulska K; Domańska-Pakieła D; Lojszczyk B; Syczewska M; Chmielewski D; Dunin-Wąsowicz D; Kmieć T; Szymkiewicz-Dangel J; Kornacka M; Kawalec W; Kuczyński D; Borkowska J; Tomaszek K; Jurkiewicz E; Respondek-Liberska M
Eur J Paediatr Neurol; 2011 Sep; 15(5):424-31. PubMed ID: 21507691
[TBL] [Abstract][Full Text] [Related]
17. Preventive Antiepileptic Treatment in Tuberous Sclerosis Complex: A Long-Term, Prospective Trial.
Jozwiak S; Słowińska M; Borkowska J; Sadowski K; Łojszczyk B; Domańska-Pakieła D; Chmielewski D; Kaczorowska-Frontczak M; Głowacka J; Sijko K; Kotulska K
Pediatr Neurol; 2019 Dec; 101():18-25. PubMed ID: 31481332
[TBL] [Abstract][Full Text] [Related]
18. Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment?
Stephen LJ; Kwan P; Brodie MJ
Epilepsia; 2001 Mar; 42(3):357-62. PubMed ID: 11442153
[TBL] [Abstract][Full Text] [Related]
19. Epileptic spasms in tuberous sclerosis complex.
Hsieh DT; Jennesson MM; Thiele EA
Epilepsy Res; 2013 Sep; 106(1-2):200-10. PubMed ID: 23796861
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.
Curatolo P
Pediatr Neurol; 2015 Mar; 52(3):281-9. PubMed ID: 25591831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
